Alcohol-induced liver disease increasingly contributes to human mortality worldwide. Alcohol-induced endoplasmic reticulum (ER) stress and disruption of cellular protein homeostasis have recently been established as a significant mechanism contributing to liver diseases. The alcohol-induced ER stress occurs not only in cultured hepatocytes but also in vivo in the livers of several species including mouse, rat, minipigs, zebrafish, and humans. Identified causes for the ER stress include acetaldehyde, oxidative stress, impaired one carbon metabolism, toxic lipid species, insulin resistance, disrupted calcium homeostasis, and aberrant epigenetic modifications. Importance of each of the causes in alcohol-induced liver injury depends on doses, duration and patterns of alcohol exposure, genetic disposition, environmental factors, cross-talks with other pathogenic pathways, and stages of liver disease. The ER stress may occur more or less all the time during alcohol consumption, which interferes with hepatic protein homeostasis, proliferation, and cell cycle progression promoting development of advanced liver diseases. Emerging evidence indicates that long-term alcohol consumption and ER stress may directly be involved in hepatocellular carcinogenesis (HCC). Dissecting ER stress signaling pathways leading to tumorigenesis will uncover potential therapeutic targets for intervention and treatment of human alcoholics with liver cancer.
1. Introduction
The endoplasmic reticulum (ER) is an essential organelle of eukaryotic cells functioning in secretory protein synthesis and processing, lipid synthesis, calcium storage/release, and detoxification of drugs. The ER ensures correct protein folding and maturation. Unfolded proteins are retained in the ER and targeted for retrotranslocation to the cytoplasm for rapid degradation. Under normal physiological conditions, there is a balance between the unfolded proteins and the ER folding machinery. Disruption of the balance results in accumulation of unfolded proteins, a condition termed ER stress [1–5]. The ER stress triggers the unfolded protein response (UPR), which attenuates protein translation, increases protein folding capacity, and promotes degradation of unfolded proteins, thus restoring ER homeostasis. However, prolonged UPR leads to an attempt to delete the cell causing injuries. Molecular chaperones such as the glucose-regulated protein 78 (GRP78/BiP) interact with three ER membrane resident stress sensors: inositol-requiring enzyme-1 (IRE1α), transcription factor-6 (ATF6), and PKR-like eukaryotic initiation factor 2α kinase (PERK), and play a vital role in maintaining the protein homeostasis inside the ER [1–5]. Many human diseases such as metabolic syndrome, neurodegenerative diseases, alcohol-induced organ disorders, and inflammatory diseases involve ER stress and impaired UPR signaling [1–7]. Increasing evidence supports ER stress as a key mechanism in alcohol-induced liver disease (ALD), a disease that affects over 140 million people worldwide. Potential molecular mechanisms underlying alcohol-induced ER stress in major organs including liver, brain, pancreas, lung, and heart have been discussed previously [8–10]. In this review, I will focus on updates and new insights into the pathogenesis of alcohol-induced ER stress and discuss an emerging role of alcohol-induced ER stress in liver tumorigenesis and hepatocellular carcinogenesis.
2. Multiple Mechanisms for Alcohol-Induced Hepatic ER Stress
Alcohol is mainly metabolized in the liver and liver cells are rich in ER, which assume synthesis of a large amount of secretory and membrane proteins. The UPR plays a pivotal role in maintaining ER homeostasis in the liver under both physiological and pathological conditions [4, 5, 9]. In the early 80s, stress-induced ER damages in the liver were observed in ultrastructural, morphological, and histological studies [43, 44]. However, little was known then about occurrence and mechanisms of alcohol-induced ER stress. A role of ER in alcohol metabolism began to be recognized as NADH from the hepatic alcohol oxidation by alcohol dehydrogenase (ADH) was also found to support microsomal alcohol oxidations [43–46]. The inducible microsomal ethanol oxidizing system (MEOS) is associated with ER proliferation and concomitant induction of cytochrome P4502E1 (CYP2E1) in rats and in humans [45, 46]. Free radical release, as a consequence of CYP2E1 activities in the ER and subsequent oxidative stress, and lipid peroxidation generally contribute to ALD. However, alcohol-induced ER stress response (AERR) that involves the UPR was not recognized until recently. Molecular evidence for an impaired UPR was first found in the mice with chronic intragastric alcohol infusion (CIAI) (Figure 1; Table 1) [11]. Alterations of some ER stress markers: GRP78, GRP94, CHOP (C/EBP homologous protein), and BAD (the Bcl-2-associated death promoter), in DNA microarrays were associated with severe steatosis, scattered apoptosis, and necroinflammation. SREBP-1c (sterol regulatory element-binding protein-1c) was found to be a strong candidate linking ER stress to alcoholic fatty liver, because SREBP-1c knockout mice were protected against triglyceride accumulation [12]. CHOP was found to be a key factor in AERR-caused cell death, as knocking out CHOP resulted in minimal alcohol-induced apoptosis in the liver [13].
Alcohol-induced endoplasmic reticulum stress (AERR) and injuries occur in many species.
Experimental system
Cause
Injury
Remark
Reference
Chronic intragastric infusion
Mouse
Hyperhomocysteinemia
Necroinflammation
Mouse strain difference
[11–13]
Methionine deficiency
Apoptosis
Rat and mouse difference
[14–18]
Acetaldehyde adducts
Fatty liver
Synergy with obesity
[19]
Rat
High SAH
Fibrosis
[20]
Low SAM/SAH
Epigenetic alterations
Chronic oral feeding
Micropig
Folate deficiency
Steatosis
[21]
Mouse
Chaperone deficiency
Apoptosis
Interaction of alcohol with
[22]
Synergy with HFD/drugs
Fibrosis
anti-HIV/HCV drugs
[23]
Excess iron
Cirrhosis
Involvement of autophagy
[24, 25]
Oxidative stress
Oxidative stress precedes AERR
[26, 27]
Acute alcohol exposure
Liver perfusion
Acetaldehyde, ROS
Fat accumulation
Role of alcohol metabolites in AERR
[28]
Mouse gavage
Synergy with drugs
Apoptosis
[22]
Ca2+ homeostasis
Fibrosis
AERR parallels LPS-TLR4
[29, 30]
Inflammation
Suppressed UPR
[31]
Zebrafish
CDIPT deficiency
Hepatomegaly
[32–34]
Nematode
Not known
Not characterized
No AERR without the liver
[35]
Alcohol treated cells
Human cells
ROS
Apoptosis
Basal ER stress in HepG2
[36–38]
Excessive homocysteine
Steatosis
Patient liver biopsies
Human alcoholics
Toxic lipid species
Apoptosis
Clinical relevance
[39–42]
Oxidative stress
Steatohepatitis
Role of mitochondrial
Insulin resistance
Fibrosis/cirrhosis
Dysfunctions in AERR
Identified molecular mechanisms for alcohol-induced endoplasmic reticulum stress and hepatic injuries. See the context for details.
Upstream of ER stress, altered methionine metabolism, and elevated homocysteine were initially proposed to be responsible for AERR because alcohol-induced hyperhomocysteinemia (HHcy) is often seen in rodents and humans [47–50] and homocysteine is known to modify proteins biochemically [8, 9, 11]. A few lines of molecular evidence support the methionine/homocysteine mechanism. First, betaine is a methyl donor for remethylation of homocysteine to methionine catalyzed partially by betaine-homocysteine methyltransferase (BHMT). Simultaneous betaine feeding or transgenic expression of BHMT in CIAI mice decreased the elevated homocysteine and abrogated AERR in parallel with decreased ALT and amelioration of ALD [11, 14, 15]. Second, an intragastric infusion with both high fat and alcohol induced moderate obesity and much severe ALD [16], which resulted from synergistic effects of an accentuated ER stress by the alcohol-induced HHcy in combination with mitochondrial stress, nitrosative stress, and adiponectin resistance. Third, rats with CIAI do not have a significant HHcy [17]. Consequently, the rat animals have a minimal ER stress response and are more resistant to ALD, which correlates with a significant induction of BHMT. Fourth, in a study with 14 inbred mouse strains with CIAI, profound differences in ALD were observed among the strains in spite of consistently high levels of urine alcohol [18]. ER stress related genes were induced only in strains with the most liver injury, which were closely associated with expression patterns of methionine metabolism-related genes and plasma homocysteine levels. Thus, abnormal protein modifications by excessive homocysteine as a result of aberrant one-carbon metabolism [18] and methionine deficiency [4] are likely responsible for the alcoholic ER stress and UPR in CIAI mice that lack a sufficient upregulation of BHMT.
However, other causes for the alcoholic ER stress are present in the CIAI model. For instance, in a study with CIAI rats to examine effects of selective inhibition of CYP2E1 on the development of alcoholic fatty liver [19], liver triglycerides were lower. ER stress indicated by the ER stress marker TRB3 (a mammalian homolog of Drosophila tribbles functions as a negative modulator of protein kinase B) was increased after ethanol and was further increased upon inhibition of CYP2E1 or overall ethanol metabolism. This suggests a contributing role of alcohol metabolites, for example, acetaldehyde, or oxidants to the alcoholic ER stress response. In another study with cystathionine β synthase (CBS) heterozygous mice treated with CIAI [20], steatohepatitis was accompanied with upregulations of hepatic ER stress components including GRP78, ATF4 (activating transcription factor 4), CHOP, and SREBP-1c and negatively correlated with S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) ratio. AERR was associated with a decrease in levels of suppressor chromatin marker trimethylated histone H3 lysine-9 (3meH3K9) in the promoter regions of the ER stress markers. Similarly, epigenetic mechanism for AERR might also occur in human alcoholics, as DNA hypermethylation of the promoter of HERP (homocysteine-induced ER protein) gene downregulates its mRNA expression in patients with alcohol dependence [51].
3. Diverse Models and Species with Alcohol-Induced ER Stress
AERR occurs not only in the aforementioned CIAI models but also in other chronic or acute models/systems (Table 1), which have been providing additional insights into AERR and ALD. In micropigs fed alcohol orally [21], liver steatosis and apoptosis were shown to be accompanied by increased mRNA levels of CYP2E1 and selective ER stress markers. Folate deficiency appeared to be responsible for the ER stress and injury. In mice, however, oral alcohol feeding ad libitum does not usually result in HHcy as remarkable as seen in the CIAI mice. Correspondingly, the degree of AERR and subsequent liver injury may depend on additional genetic and/or dietary factors. For instance, in the mice with liver specific deletion of GRP78/BiP [22], a robust ER stress response was observed at moderate oral alcohol doses (e.g., 4 g/kg), which was accompanied by much aggravated hepatosteatosis and hepatic fibrosis. Thus, compared to the homocysteine-ER stress mechanism, the liver BiP deletion represents a genetic predisposition that unmasks a distinct mechanism by which alcohol induces ER stress, one that is largely obscured by compensatory changes in normal animals or presumably in the majority of human population who have low-to-moderate drinking [8, 22]. The effect of genetic predisposition on AERR and hepatic injury is also observed in a recent study using mice with low alcohol-induced plasma homocysteine and deficient in the acid sphingomyelinase (ASMase) [23]. Strong AERR and enhanced susceptibility to lipopolysaccharides (LPS) or concanavalin-A were present in ASMase −/− mice fed alcohol orally, indicative of a mitochondrial effect on AERR. In addition, in iron overloaded mice deficient in the hemochromatosis gene (Hfe−/−), cofeeding ad libitum with alcohol and a high-fat diet (HFD) led to profound steatohepatitis and fibrosis [24, 25]. XBP1 splicing, activation of IRE-1α and PERK, and increased CHOP protein expression were associated with impaired autophagy response, suggesting that preconditioning with iron overloading may modulate AERR and promote liver injury through interacting with other adaptive or compensatory mechanisms.
Alternatively, the contributing role of ER stress to ALD in oral feeding models could be secondary. This is indicated by a time-course study with a mouse model of early-stage ALD [26]. Mice with oral alcohol feeding exhibited significant hepatic steatosis and elevated plasma ALT values. At 1 to 2 weeks after alcohol feeding, oxidative stress indicated by 4-hydroxynonenal- (4-HNE-) modified proteins was increased, whereas hepatic glutathione (GSH) levels were significantly decreased as a consequence of decreased CBS activity, increased GSH utilization, and increased protein glutathionylation. Except for 4-HNE adduction to the ER disulfide isomerase (PDI), significant upregulations of other ER markers and SREBP pathways were not detected in vivo during the same early period of alcohol feeding [26, 27]. Although the actual blood alcohol levels were not measured in this study, which might not reach a critical point and vary widely among individual mice at a liberal access to alcohol, the results may suggest a secondary role of AERR in this early ALD model. Thus, interplay or cross-talk between AERR and other stresses might be critical in ALD. This notion is supported by a few most recent reports, which appears more evident in cell or animal models with acute alcohol exposure. First, cell death is not readily observed in acute ethanol intoxication. However, in a perfused rat liver system, downregulation of GRP78 and activation of c-Jun N-terminal kinase (JNK) and protein kinase B (PKB/Akt) were enhanced by a cotreatment of acute ethanol with a classical inhibitor of ADH, and an antioxidant addition reduced the activation of JNK and cell death [28]. High concentrations of the pharmacological ER stress-inducing agents such as tunicamycin or brefeldin A activate JNK and inhibit mitochondrial respiration and cell death in hepatocytes [52]. Mitochondrial respiration has been shown to play an adaptive role in ALD [53]. Thus, ethanol metabolites and/or impaired mitochondrial functions may complicate AERR. Second, the mice with liver specific GRP78 deletion are sensitized to a variety of acute hepatic disorders by alcohol, a high-fat diet, anti-HIV drugs, or toxins [22]. HIV protease inhibitors inhibit the ER Ca2+ATPase (SERCA) and modulate calcium homeostasis in mice and primary human hepatocytes, which aggravates AERR and ALD [29]. Alcohol-induced LPS impairs UPR promoting rat liver cirrhosis [30]. Third, the interferon regulatory factor 3 (IRF3) is activated early by ER stress in mice fed alcohol either orally or intragastrically, which involves an ER adaptor, the stimulator of interferon genes (STING) [31]. Independent of inflammatory cytokines and Type-I interferons (IFNs), IRF3 exerts its pathogenic role in ALD through causing apoptosis of hepatocytes, which strongly suggests that AERR pathways and the LPS-TLR4 (toll-like receptor 4) pathways [54] are parallel or equally important in initiating ALD.
In addition to rodents, AERR has also been found in other species including human alcoholics (Table 1). Zebrafish larvae represent an alternative vertebrate model for studying AERR and ALD because their liver possesses the pathways to metabolize alcohol that can be simply added to the water, that is, acute alcohol [32]. AERR is present in alcohol-treated zebrafish, which may also interact with other pathological factors. Upon alcohol challenge, zebrafish larvae developed signs of acute ALD, including hepatomegaly and steatosis. Further, the ER stress response appeared much robust in zebrafish deficient in the CDP-diacylglycerol-inositol 3-phosphatidyltransferase (CDIPT) that primarily locates on the cytosolic aspect of the ER [33]. Thus, integrity of the ER or alcohol metabolism might be necessary for AERR [34]. In supporting this, in the species Caenorhabditis elegans without a liver for alcohol digestion/metabolism, little AERR has been detected [35]. The most important and clinically relevant studies regarding AERR are from human cells and patients. AERR is reported in human monocyte-derived dendritic cells (MDDC) [36], HepG2 cells expressing human CYP2E1 [37], and primary human hepatocytes [29]. Oxidative stress resulted from the function of CYP2E1 and/or interactions with other drugs contributing to AERR in the human cells. However, cultured human cell models may not reflect the complexity of the response in vivo. For instance, it was reported that, upon alcohol exposure, VL-17A cells metabolized alcohol which caused ER fragmentation inside the cells, but little activation of UPR target genes was detected [38]. Nevertheless, striking upregulation of multiple ER stress signaling molecules was detected in human patients with ALD (Table 1) [39–42], which is correlated with deregulated lipid metabolism, ceramide accumulation, and impaired insulin signaling, indicating that AERR is an integrated part of pathogenesis of ALD in human alcoholics.
4. Emerging Role of AERR in Liver Tumorigenesis and HCC
It has been well accepted that the UPR is a double-edged response because both adaptive survival and eliminative apoptosis can be induced by UPR components [1–6]. It is beneficial or prosurvival if it happens transiently or lasts for a short period of time, whereas it is detrimental or deadly if it is prolonged. Recent studies indicate that the UPR is associated with solid tumor development in many types of tissues or organs including the liver [55, 56]. Since the microenvironments of solid tumors are generally hypoxic, acidic, and nutrient deficient [57, 58], which individually or collectively favor activation of ER stress response, it is conceivable that the UPR is persistently present during tumorigenesis. The question is how the cancer cells evade cell death from the prolonged UPR. Emerging evidence suggests that cancerous cells could modify and perturb the ER stress-associated cell death signaling, which permits survival and growth. For instance, the master regulator UPR, GRP78, plays a dual role in tumor cells [22, 59]. It controls early tumor development through suppressive mechanisms such as the induction of cell cycle arrest or tumor dormancy upon PERK activation [60]. On the other hand, at more advanced stages of tumor progression, during which cells are exposed to more severe stressors, GRP78 suppresses caspase 7 activation and interacts with ER stress-induced protein chaperones such as clusterin to promote cell survival and further tumor development [61]. The PERK-eIF2α-ATF4 pathway is often activated by the hypoxic condition in solid tumors [62–64], which activates angiogenic genes, vascular endothelial growth factor (VEGF), type 1 collagen inducible protein, and autophagosome components such as LC3, ensuring cell survival over hypoxia-induced ER stress [65–67]. Prolonged expression and activation of ATF6 increase the Rheb-mTOR signaling pathway and also enhance tumor cell survival [68]. In addition, the IRE1α-Xbp1 pathway interacts with antiapoptotic Bcl-2 family members and the sigma-1 receptor, which is often increased in many human cell lines [69–72]. Therefore, impaired and/or prolonged UPR has a high potential to modulate cell fates and differentiations towards tumorigenesis.
Alcohol intake increasingly contributes to mortality from liver cancer in humans [73–76]. However, the mechanisms by which alcohol exerts its carcinogenic effect are largely unknown and currently there is no effective treatment. Considering that several lines of evidence indicate that polymorphic responses of major ER chaperones to alcohol and other stressors are associated with hepatocellular carcinogenesis in human populations [77–82], it is not unusual to find a role of AERR in HCC. In fact, we recently found spontaneous hepatocellular adenomas- (HCA-) like tumors in aged female mice with a liver specific BiP deletion and under constitutive ER stress [22, 59, 83]. Active ATF6, CHOP, GSK3β, and Creld2 (cysteine rich with EGF-like domains 2) were increased in the knockout, indicative of continuous ER stress response. None of p53, HNF1α, or GP130 was significantly changed compared between wild type and knockout. β-Catenin was slightly decreased. Interestingly, cyclin D was specifically reduced in the tumor portion of the knockout mice. Since most liver tumors were found in female knockouts, expression of receptors for sex hormones such as estrogen receptors, ERα and β, and androgen receptor, ARα, was examined. Three variants of ERα were detected in the liver, and their molecular sizes are 66 kD, 46 kD, and 36 kD, respectively [83]. The ERα variant 36 kD was remarkably increased in the tumor portion of the knockout liver. In contrast, there were no significant changes in the expression of ERβ, ARα, cyclin E, or cyclin G. These findings revealed thatinhibition of cyclin D and overexpression of ER variant 36 kD are associated with the tumor development in the female knockouts under constitutive ER stress [83]. Furthermore, the tumors are highly malignant in mice with additional stresses such as high-fat diet or alcohol intake [83, 84]. The pathways of ERK1/2, Stat3, and p38 were activated, which are known to promote HCC progression [85, 86].
The constitutive ER stress-induced spontaneous liver tumors that are dominant in female animals are similar to human HCA [87–90], which are of clinical relevance since about 80% of HCA cases are from women taking oral contraceptives for years [90, 91]. The pathogenesis of HCA is not completely understood due to its heterogeneity. Known potential causesfor human HCA are mutations in HNF1α, β-catenin, GP130, or chronic inflammation [87–93]. Hepatocellular protein homeostasis has rarely been noticed to be a potential mechanism for HCA development. Thus, the above findings on cyclin D and ERα variants may reveal a novel ER stress mechanism for HCA for several reasons (Figure 2). First, the in vivo inhibition of cyclin D expression upon ER stress in knockouts is consistent with an earlier study, which demonstrated that activation of the UPR in mouse NIH 3T3 fibroblasts with tunicamycin led to a decline in cyclin D and subsequent G(1) phase arrest [94–96]. Second, increased expression of cyclin D is usually associated with proliferation in other systems [97]. However, a number of studies have shown many new roles of cyclin D [98] and a surprising lack of the correlation of increased cyclin D with proliferation in tumors [99, 100]. For instance, in one subtype of human breast carcinoma, cyclin D1 protein expression was absent in the noninvasive cells [101, 102]. Similarly, a loss of cyclin D did not inhibit the proliferative response of mouse liver to mitogenic stimuli [103] and mRNA levels of cyclin D1 were downregulated in patients with HCC [104]. Most recent molecular evidence further supports this ER stress-cyclin D-tumorigenesis mechanism. Nrf2 (the nuclear factor erythroid 2-related factor 2) activities are associated with aging [105]. ER stress activates Nrf2 and ATF6, both of which regulate the orphan nuclear receptor, Shp (small heterodimer partner) which acts as a transcriptional corepressor modulating cyclin D1 and subsequent hepatic tumorigenesis [106, 107]. The ER stress sensor PERK has been shown to phosphorylate the Forkhead transcription factor 3 (FOXO3) [108] and suppressed FOXO3 exacerbates alcoholic hepatitis and insulin resistance impairing cyclin D function promoting HCC [109–111]. Thus, abnormal functions of cyclin D under ER stress conditions most likely disturb liver cell proliferation (Figure 2). Third, since the authentic ERα66 interacts with cyclin D physically [100, 101], the hepatic ERα variants may result from an unbalanced long-term molecular interaction between ERα and the suppressed cyclin D under ER stress (Figure 2). Alternatively, the ERα variants may be produced from an incomplete protein processing/maturation of ERα by an impaired ER-associated degradation (ERAD). Components of ERAD are indeed altered in the BiP knockout mouse models under constitutive UPR [22, 59, 83, 84], and there is a report indicating that an activation of the Xbp1-Hrd1 (an E3 ubiquitin ligase also called synoviolin) branch by the UPR facilitates Nrf2 ubiquitylation and degradation during liver cirrhosis [112]. Similarly, ERα could also be a target of the impaired ERAD. Fourth, considering that ERα gene polymorphism is associated with risk of HBV-related acute liver failure [113] and a switch from the authentic ERα to a predominant expression of ERα36 is associated with development and progression of HCC [114–116], the hepatic ERα variants could also play an important role in alcohol and ER stress-associated HCC. The tumorigenic signaling downstream of cyclin D and ERα variants can be activations of the ERK1/2, IP3K-PKC, or JAK-STAT pathways [117]. Overexpressed ERα36 has been associated with activation of these pathways and carcinogenesis in other systems such as breast cancer and gastric cancer [118–122]. In the liver, activations of ERK1/2 and JAK-STAT pathways were observed in the BiP knockout mice fed alcohol and high-fat diet [83, 84]. Finally, studies on hepatoma cell lines, HCC tissues, and animal models of HCC suggest a possible role of sex hormones and their receptors in HCC pathogenesis [123]. A male prevalence of HCC is often observed in young and middle aged patient populations in certain regions exposed to additional HCC risk factors [124]. However, the male prevalence of HCC tends to diminish in aged human populations [125] as well as in aged animals fed alcohol [83, 84]. Therefore, alcohol-induced ER stress and cell cycle impairment may exert specific effects on aging, hepatic expression of estrogen receptors, and subsequent tumorigenesis in females.
Proposed model depicts novel endoplasmic reticulum (ER) stress mechanisms linking alcohol (EtOH) and/or high-fat diet (HFD), cyclin D, ERAD, estrogen receptor α (ERα) variants, FOXO3, and Shp with hepatocellular carcinogenesis (HCC). Solid lines represent established pathways based on the literature; dashed lines represent emerging mechanisms under investigations. See the context for details.
5. Conclusive Remarks
Alcohol-induced hepatic ER stress occurs in the liver of many species including human alcoholics, which has recently been established as an important mechanism for both acute and chronic alcohol-induced liver pathogenesis and disease development. Multiple factors commonly associated with alcohol consumption such as acetaldehyde, oxidative stress, excessive homocysteine, toxic lipid species, increased SAH, aberrant epigenetic modifications, disruption of calcium homeostasis, and insulin resistance induce ER stress response individually or collectively. However, the precise contribution of each of the factors to the ER stress induction is not clear and their importance to ALD may depend on doses, duration and patterns of alcohol exposure, presence or absence of genetic and environmental factors, cross-talks with other pathogenic pathways, and liver disease stages. The UPR, as an integrated part of liver physiology and pathology like the immune response, may occur more or less all the time during alcohol consumption, which attempts to restore ER homeostasis and protect against ALD. However, this adaptive protection is not without detrimental consequences. Prolonged UPR leads to excessive deletion of the damaged hepatocytes or cell cycle arrest, which triggers inflammatory response or interrupts normal cellular processes causing profound injuries. Emerging evidence by us and others indicates a direct involvement of long-term alcohol and constitutive ER stress in liver tumorigenesis and hepatocellular carcinogenesis. The ER stress and malfunctioning of cyclin D-caused cell cycle arrest are a well-established molecular mechanism, and the surprise overexpression of estrogen receptor α variants under constitutive UPR may result from a mal-targeting of protein processing and turnover by aberrant ERAD, which reflect complexity and depth of prolonged UPR-mediated pathogenesis. Thus, liver tumorigenesis by alcohol and ER stress may involve not only cyclin D, ERα variants, ERK1/2, PKC, and STAT pathways, but also other cell cycle targets such as IL-6, p21, p27, and CDK, other pathways such as Src/EGFR, PTEN-TGFβ, and insulin/IGF, and epigenetic regulations such as miRNAs targeting the UPR components. In addition, liver progenitor cell activation by alcohol may contribute to the malignant transformation of nonmalignant tumors developed under long-term ER stress [22, 59]. Future work should be directed to define the ER stress mechanisms leading to HCC and to develop multiple therapeutic approaches to target ER stress in human alcoholics with HCC.
AbbreviationsADH:
Alcohol dehydrogenase
AERR:
Alcohol-induced ER stress response
ALD:
Alcohol-induced liver disease
ARα:
Androgen receptor α
ASMase:
The acid sphingomyelinase
ATF 4 or 6:
Activating transcription factor 4 or 6
BAD:
The Bcl-2-associated death promoter
BiP:
Binding immunoglobulin protein also known as 78 kDa glucose-regulated protein (GRP78)
Activation of the epidermal growth factor receptor
ER:
Endoplasmic reticulum
ERα:
Estrogen receptors α
ERAD:
ER-associated degradation
ERK1/2:
Extracellular signal-regulated protein kinases 1 and 2
FOXO3:
The forkhead transcription factor
HCA:
Hepatocellular adenomas
HCC:
Hepatocellular carcinogenesis
HERP:
Homocysteine-induced ER protein
HFD:
High-fat diet
HHcy:
Hyperhomocysteinemia
4-HNE:
4-Hydroxynonenal
HNF1α:
Hepatocyte nuclear factor 1α
Hrd1:
An E3 ubiquitin ligase also called synoviolin
GADD34:
Growth arrest and DNA damage-inducible protein 34
GSH:
Glutathione
GP130:
Glycoprotein 130
GSK3β:
Glycogen synthase kinase 3β
IGF:
Insulin-like growth factor
IRE1α:
Inositol-requiring enzyme-1α
IRF3:
The interferon regulatory factor 3
JAK:
Janus kinase
JNK:
c-Jun N-terminal kinases
LC3:
Microtubule-associated protein 1A/1B-light chain 3
LPS:
Lipopolysaccharides
Mito:
Mitochondria
MDDC:
Human monocyte-derived dendritic cells
MEOS:
The inducible microsomal ethanol oxidizing system
mTOR:
Mammalian target of rapamycin
NFκB:
Nuclear factor κB
PDI:
The ER disulfide isomerase
Nrf2:
The nuclear factor erythroid 2-related factor 2
PGC1:
PPARγ coactivator 1
PERK:
PKR-like ER-localized eIF2α kinase
PKC:
Protein kinase C
PTEN:
Phosphatase and tensin homolog
ROS:
Reactive oxygen species
SAH:
S-Adenosylhomocysteine
SAM:
S-Adenosylmethionine
SERCA:
ER calcium transport ATPase
Shp:
Small heterodimer partner
SIRT1:
Silent mating type information regulation 2 homolog 1
SRC:
Protooncogene tyrosine-protein kinase
SREBP:
Sterol regulatory element-binding protein
STING:
An ER adaptor, the stimulator of interferon genes
Stat3:
Signal transducer and activator of transcription 3
TGFα:
Transforming growth factor α
TLR4:
Toll-like receptor 4
TRB3:
A mammalian homolog of Drosophila tribbles functions as a negative modulator of protein kinase B (PKB)
TRAF2:
TNF receptor-associated factor 2
TUDCA:
Tauroursodeoxycholate
UPR:
The unfolded protein response
VEGF:
Vascular endothelial growth factor
XBP1:
X-box binding protein 1.
Conflict of Interests
The author declares that there is no conflict of interests regarding the publication of this paper.
Acknowledgments
This work is supported by the US National Institute of Health (NIH) Grants R01AA018612, R01AA014428, and R01AA018846. The author is grateful to the graduate students and postdoctoral fellows who contributed to the studies in his lab.
WalterP.RonD.The unfolded protein response: from stress pathway to homeostatic regulation20113346059108110862-s2.0-8225517396610.1126/science.1209038CaoS. S.KaufmanR. J.Targeting endoplasmic reticulum stress in metabolic disease2013174437448FuS.WatkinsS. M.HotamisligilG. S.The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling20121556236342-s2.0-8486048372710.1016/j.cmet.2012.03.007HenkelA.GreenR. M.The unfolded protein response in Fatty liver disease2013334321329WolffS.WeissmanJ. S.DillinA.Differential scales of protein quality control201415715264OzcanL.TabasI.Role of endoplasmic reticulum stress in metabolic disease and other disorders2012633173282-s2.0-8485596672110.1146/annurev-med-043010-144749KitamuraM.The unfolded protein response triggered by environmental factors2013353259275JiC.Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury2008231S16S242-s2.0-4074908320610.1111/j.1440-1746.2007.05276.xJiC.Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries20122012122-s2.0-8485528186810.1155/2012/216450216450KaphaliaL.BoroumandN.HyunsuJ.KaphaliaB. S.CalhounW. J.Ethanol metabolism, oxidative stress, and endoplasmic reticulum stress responses in the lungs of hepatic alcohol dehydrogenase deficient deer mice after chronic ethanol feeding201410.1016/j.taap.2014.02.018JiC.KaplowitzN.Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice20031245148814992-s2.0-003796012810.1016/S0016-5085(03)00276-2JiC.ChanC.KaplowitzN.Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model20064557177242-s2.0-3374925371310.1016/j.jhep.2006.05.009JiC.Mehrian-ShaiR.ChanC.HsuY.-H.KaplowitzN.Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding2005298149615032-s2.0-2414447228710.1097/01.alc.0000174691.03751.11JiC.ShinoharaM.KuhlenkampJ.ChanC.KaplowitzN.Mechanisms of protection by the betaine-homocysteine methyltransferase/ betaine system in HepG2 cells and primary mouse hepatocytes2007465158615962-s2.0-3634903221310.1002/hep.21854JiC.ShinoharaM.VanceD.ThanT. A.OokhtensM.ChanC.KaplowitzN.Effect of transgenic extrahepatic expression of betaine-homocysteine methyltransferase on alcohol or homocysteine-induced fatty liver2008326104910582-s2.0-4434912450110.1111/j.1530-0277.2008.00666.xXuJ.LaiK. K. Y.VerlinskyA.LugeaA.FrenchS. W.CooperM. P.JiC.TsukamotoH.Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK20115536736822-s2.0-8486038925810.1016/j.jhep.2010.12.034ShinoharaM.JiC.KaplowitzN.Differences in betaine-homocysteine methyltransferase expression, endoplasmic reticulum stress response, and liver injury between alcohol-fed mice and rats20105137968052-s2.0-7795061240810.1002/hep.23391TsuchiyaM.JiC.KosykO.ShymonyakS.MelnykS.KonoH.TryndyakV.MuskhelishviliL.PogribnyI. P.KaplowitzN.RusynI.Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice2012561130139RonisM. J.KorourianS.BlackburnM. L.BadeauxJ.BadgerT. M.The role of ethanol metabolism in development of alcoholic steatohepatitis in the rat20104421571692-s2.0-7724909301210.1016/j.alcohol.2009.11.002EsfandiariF.MediciV.WongD. H.JoseS.DolatshahiM.QuinlivanE.DayalS.LentzS. R.TsukamotoH.ZhangY. H.FrenchS. W.HalstedC. H.Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse20105139329412-s2.0-7795062283310.1002/hep.23382EsfandiariF.VillanuevaJ. A.WongD. H.FrenchS. W.HalstedC. H.Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs20052891G54G632-s2.0-2174443642210.1152/ajpgi.00542.2004JiC.KaplowitzN.LauM. Y.KaoE.PetrovicL. M.LeeA. S.Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice20115412292392-s2.0-7995954418910.1002/hep.24368FernandezA.MatiasN.FuchoR.ASMase is required for chronic alcohol induced hepaticendoplasmic reticulum stress and mitochondrial cholesterol loading2013594805813TanT. C.CrawfordD. H.JaskowskiL. A.SubramaniamV. N.CloustonA. D.CraneD. I.BridleK. R.AndersonG. J.FletcherL. M.Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury2013931212951312TanT. C.CrawfordD. H.JaskowskiL. A.MurphyT. L.SantrampurwalaN.CraneD.CloustonA. D.SubramaniamV. N.AndersonG. J.FletcherL. M.A corn oil-based diet protects against combined ethanol and iron-induced liver injury in a mouse model of hemochromatosis2013371016191631GalliganJ. J.SmathersR. L.FritzK. S.EppersonL. E.HunterL. E.PetersenD. R.Protein carbonylation in a murine model for early alcoholic liver disease201225510121021GalliganJ. J.SmathersR. L.ShearnC. T.FritzK. S.BackosD. S.JiangH.FranklinC. C.OrlickyD. J.MacleanK. N.PetersenD. R.Oxidative stress and the ER stress response in a murine model for early-stage alcoholic liver disease201220121220759410.1155/2012/207594NishitaniY.MatsumotoH.Ethanol rapidly causes activation of JNK associated with ER stress under inhibition of ADH200658019142-s2.0-2934446824610.1016/j.febslet.2005.11.030KaoE.ShinoharaM.FengM.LauM. Y.JiC.Human immunodeficiency virus protease inhibitors modulate Ca(2+) homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes2012562594604TaziK. A.BiècheI.ParadisV.GuichardC.LaurendeauI.DargèreD.LegrandA.FayM.PedruzziE.RobinM.-A.Cazals-HatemD.TellierZ.BernuauD.FeldmannG.VidaudM.LebrecD.Ogier-DenisE.MoreauR.In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats2007466107510882-s2.0-3424758505410.1016/j.jhep.2007.01.034PetrasekJ.Iracheta-VellveA.CsakT.SatishchandranA.KodysK.Kurt-JonesE. A.FitzgeraldK. A.SzaboG.STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease2013110411654416549PasseriM. J.CinarogluA.GaoC.SadlerK. C.Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation20094924434522-s2.0-6194934987310.1002/hep.22667ThakurP. C.StuckenholzC.RiveraM. R.DavisonJ. M.YaoJ. K.AmsterdamA.SadlerK. C.BaharyN.Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish20115424524622-s2.0-7996073985010.1002/hep.24349TsedensodnomO.VacaruA. M.HowarthD. L.YinC.SadlerK. C.Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease20136512131226IentB.EdwardsR.MouldR.HannahM.Holden-DyeL.O'ConnorV.HSP-4 endoplasmic reticulum (ER) stress pathway is not activated in a C. elegans model of ethanol intoxication and withdrawal201212293102BoukliN. M.SaiyedZ. M.RicaurteM.RodriguezJ. W.Ríos OlivaresE.CubanoL. A.NairM. P. N.Implications of ER stress, the unfolded protein response, and pro- and anti-apoptotic protein fingerprints in human monocyte-derived dendritic cells treated with alcohol20103412208120882-s2.0-7864959666310.1111/j.1530-0277.2010.01304.xMagneL.BlancE.LegrandB.LucasD.BaroukiR.RouachH.GarlattiM.ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes20115447297372-s2.0-7995269882210.1016/j.jhep.2010.07.023HowarthD. L.VacaruA. M.TsedensodnomO.MormoneE.NietoN.CostantiniL. M.SnappE. L.SadlerK. C.Alcohol disrupts endoplasmic reticulum function and protein secretion in hepatocytes201236114232-s2.0-8485530576310.1111/j.1530-0277.2011.01602.xLongatoL.RippK.SetshediM.Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease201220121747934810.1155/2012/479348RamirezT.LongatoL.DostalekM.TongM.WandsJ. R.de la MonteS. M.Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis20134813952RamirezT.TongM.ChenW. C.NguyenQ. G.WandsJ. R.de la MonteS. M.Chronic alcohol-induced hepatic insulin resistance and ER stress ameliorated by PPAR-δ, agonist treatment2013281179187TongM.LongatoL.RamirezT.ZabalaV.WandsJ. R.de la MonteS. M.Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin20149514963CintiD. L.GrundinR.OrreniusS.The effect of ethanol on drug oxidations in vitro and the significance of ethanol-cytochrome P-450 interaction19731342367375LieberC. S.Microsomal ethanol-oxidizing system1987371-245562-s2.0-0023098926LieberC. S.The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role2004363-45115292-s2.0-754422239510.1081/DMR-200033441LieberC. S.Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years2005507202-s2.0-33644826328BarakA. J.BeckenhauerH. C.TumaD. J.BadakhshS.Effects of prolonged ethanol feeding on methionine metabolism in rat liver19876532302332-s2.0-0023091198BlascoC.CaballeríaJ.DeulofeuR.LligoñaA.ParésA.LluisJ. M.GualA.RodésJ.Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics200529610441048HultbergB.BerglundM.AnderssonA.FrankA.Elevated plasma homocysteine in alcoholics19931736876892-s2.0-0027231298LutzU. C.Alterations in homocysteine metabolism among alcohol dependent patients—clinical, pathobiochemical and genetic aspects20081147552-s2.0-68549101818BleichS.LenzB.ZiegenbeinM.BeutlerS.FrielingH.KornhuberJ.BönschD.Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence20063045875912-s2.0-3364536804810.1111/j.1530-0277.2006.00068.xWinS.ThanT. A.Fernandez-ChecaJ. C.KaplowitzN.JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death20145, article e98910.1038/cddis.2013.522HanD.YbanezM. D.JohnsonH. S.McDonaldJ. N.MesropyanL.SanchetiH.MartinG.MartinA.LimA. M.DaraL.CadenasE.TsukamotoH.KaplowitzN.Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations2012287504216542179InokuchiS.TsukamotoH.ParkE.LiuZ.-X.BrennerD. A.SekiE.Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice2011358150915182-s2.0-7995981171810.1111/j.1530-0277.2011.01487.xVandewynckelY. P.LaukensD.GeertsA.BogaertsE.ParidaensA.VerhelstX.JanssensS.HeindryckxF.van VlierbergheH.The paradox of the unfolded protein response in cancer2013331146834694WangW. A.GroenendykJ.MichalakM.Endoplasmic reticulum stress associated responses in cancer201410.1016/j.bbamcr.2014.01.012BrownJ. M.GiacciaA. J.The unique physiology of solid tumors: opportunities (and problems) for cancer therapy1998587140814162-s2.0-0032053823GiacciaA. J.BrownJ. M.WoutersB.DenkoN.KoumenisC.Cancer therapy and tumor physiology1998279534712132-s2.0-0032472232LeeA. S.Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential2014144263276WestonR. T.PuthalakathH.Endoplasmic reticulum stress and BCL-2 family members201068765772-s2.0-7795813233410.1007/978-1-4419-6706-0_4WangC.JiangK.GaoD.Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78201382, article e55981MartinonF.Targeting endoplasmic reticulum signaling pathways in cancer2012517822830KoumenisC.ER stress, hypoxia tolerance and tumor progression20066155692-s2.0-3364616740010.2174/156652406775574604FelsD. R.KoumenisC.The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth200657723728BlaisJ. D.AddisonC. L.EdgeR.FallsT.ZhaoH.WaryK.KoumenisC.HardingH. P.RonD.HolcikM.BellJ. C.Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress20062624951795322-s2.0-3384546557810.1128/MCB.01145-06RzymskiT.MilaniM.PikeL.BuffaF.MellorH. R.WinchesterL.PiresI.HammondE.RagoussisI.HarrisA. L.Regulation of autophagy by ATF4 in response to severe hypoxia20102931442444352-s2.0-7795546731910.1038/onc.2010.191CojocariD.VellankiR. N.SitB.UehlingD.KoritzinskyM.WoutersB. G.New small molecule inhibitors of UPR activation demonstrate that PERK, but not IRE1α, signaling is essential for promoting adaptation and survival to hypoxia20131083541547ScheweD. M.Aguirre-GhisoJ. A.ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo20081053010519105242-s2.0-4874910509310.1073/pnas.0800939105HetzC.BernasconiP.FisherJ.LeeA.-H.BassikM. C.AntonssonB.BrandtG. S.IwakoshiN. N.SchrinzelA.GlimcherL. H.KorsmeyerS. J.Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1α200631257735725762-s2.0-3364623782310.1126/science.1123480RodriguezD. A.ZamoranoS.LisbonaF.Rojas-RiveraD.UrraH.Cubillos-RuizJ. R.ArmisenR.HenriquezD. R.H ChengE.LetekM.VaisarT.IrrazabalT.Gonzalez-BillaultC.LetaiA.Pimentel-MuiñosF. X.KroemerG.HetzC.BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α20123110223524372-s2.0-8485972947610.1038/emboj.2012.84VilnerB. J.De CostaB. R.BowenW. D.Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability1995151, part 11171342-s2.0-0028876578HayashiT.SuT.-P.Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival200713135966102-s2.0-3554900679710.1016/j.cell.2007.08.036GrewalP.ViswanathenV. A.Liver cancer and alcohol2012164839850WarrenK. R.MurrayM. M.Alcoholic liver disease and pancreatitis: global health problems being addressed by the US National Institute on Alcohol Abuse and Alcoholism201328supplement 146FriedmannP. D.Alcohol use in adults20133681716551656GunzerathL.HewittB. G.LiT.-K.WarrenK. R.Alcohol research: past, present, and future2011121611232-s2.0-7925149474010.1111/j.1749-6632.2010.05832.xZhuX.ZhangJ.FanW.The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma201334612731280WinderT.BohanesP.ZhangW.YangD.PowerD. G.NingY.GergerA.WilsonP. M.TangL. H.ShahM.LeeA. S.LenzH.-J.Grp78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients20112211243124392-s2.0-8015512437910.1093/annonc/mdq771ZhuX.ChenL.FanW.LinM. C. M.TianL.WangM.LinS.WangZ.ZhangJ.WangJ.YaoH.KungH.LiD.An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers2011672-s2.0-7996029295710.1371/journal.pone.0021997e21997ZhuX.ChenM.-S.TianL.-W.LiD.-P.XuP.-L.LinM. C. M.XieD.KungH.-F.Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis20091256135213572-s2.0-6824915479610.1002/ijc.24487LiuS.LiK.LiT.Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese han population201332311912410.1089/dna.2012.1909MerrickD. T.GRP78, intronic polymorphisms, and pharmacogenomics in non-small cell lung cancer2012141613771378LauM. Y.HanH.HuJ.JiC.Association of cyclin D and estrogen receptor α36 with hepatocellular adenomas of female mice under chronic endoplasmic reticulum stress2013283576583HanH.HuJ.LauM. Y.FengM.PetrovicL. M.JiC.Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumors20134, article 224GiannelliG.NapoliN.AntonaciS.Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma20071332330133042-s2.0-3674909453510.2174/138161207782360609MuntanéJ.De la RosaA. J.DocoboF.García-CarboneroR.PadilloF. J.Targeting tyrosine kinase receptors in hepatocellular carcinoma2013133300312Bioulac-SageP.TaoujiS.PossentiL.BalabaudC.Hepatocellular adenoma subtypes: the impact of overweight and obesity2012328121712212-s2.0-8485841849010.1111/j.1478-3231.2012.02786.xNaultJ.-C.Zucman-RossiJ.Genetics of hepatobiliary carcinogenesis20113121731872-s2.0-7995563155810.1055/s-0031-1276646KatabathinaV. S.MeniasC. O.ShanbhogueA. K. P.JagirdarJ.PaspulatiR. M.PrasadS. R.Genetics and imaging of hepatocellular adenomas: 2011 update2011316152915432-s2.0-84857436993LinH.Van Den EsschertJ.LiuC.Van GulikT. M.Systematic review of hepatocellular adenoma in China and other regions201126128352-s2.0-7865037886610.1111/j.1440-1746.2010.06502.xEdmondsonH. A.HendersonB.BentonB.Liver cell adenomas associated with use of oral contraceptives197629494704722-s2.0-0017253557Bioulac-SageP.CubelG.BalabaudC.Zucman-RossiJ.Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers2011311911032-s2.0-7995192478710.1055/s-0031-1272837GuichardC.AmaddeoG.ImbeaudS.LadeiroY.PelletierL.MaadI. B.CalderaroJ.Bioulac-SageP.LetexierM.DegosF.ClémentB.BalabaudC.ChevetE.LaurentA.CouchyG.LetouzéE.CalvoF.Zucman-RossiJ.Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma2012446946982-s2.0-8486059367510.1038/ng.2256BrewerJ. W.HendershotL. M.SherrC. J.DiehlJ. A.Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression19999615850585102-s2.0-003358767510.1073/pnas.96.15.8505BrewerJ. W.DiehlJ. A.PERK mediates cell-cycle exit during the mammalian unfolded protein response2000972312625126302-s2.0-003373962210.1073/pnas.220247197HamanakaR. B.BennettB. S.CullinanS. B.DiehlJ. A.PERK and GCN2 contribute to eIF2α phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway20051612549355012-s2.0-2864444187510.1091/mbc.E05-03-0268KimJ. K.DiehlJ. A.Nuclear cyclin D1: an oncogenic driver in human cancer200922022922962-s2.0-6764935263710.1002/jcp.21791PestellR. G.New roles of cyclin D12013183139MusgroveE. A.CaldonC. E.BarracloughJ.StoneA.SutherlandR. L.Cyclin D as a therapeutic target in cancer20111185585722-s2.0-7996083682310.1038/nrc3090FuM.WangC.LiZ.SakamakiT.PestellR. G.Minireview: cyclin D1: normal and abnormal functions200414512543954472-s2.0-944423689510.1210/en.2004-0959OyamaT.KashiwabaraK.YoshimotoK.ArnoldA.KoernerF.Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast19985813287628802-s2.0-0032126542ShokerB. S.JarvisC.DaviesM. P. A.IqbalM.SibsonD. R.SloaneJ. P.Immunodetectable cyclin D1 is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions2001848106410692-s2.0-003591761710.1054/bjoc.2001.1705Ledda-ColumbanoG. M.PibiriM.ConcasD.CossuC.TripodiM.ColumbanoA.Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli2002365109811052-s2.0-003682976710.1053/jhep.2002.36159LuJ. W.LinY. M.ChangJ. G.YehK. T.ChenR. M.TsaiJ. J.SuW. W.HuR. M.Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma2013301, article 379SuhJ. H.ShenviS. V.DixonB. M.LiuH.JaiswalA. K.LiuR.-M.HagenT. M.Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid200410110338133862-s2.0-154272349310.1073/pnas.0400282101ZhangY.WangL.Nuclear receptor small heterodimer partner in apoptosis signaling and liver cancer2011311982122-s2.0-7995370256610.3390/cancers3010198ZhangY.HagedornC. H.WangL.Role of nuclear receptor SHP in metabolism and cancer2011181288939082-s2.0-7995824370210.1016/j.bbadis.2010.10.006ZhangW.HietakangasV.WeeS.LimS. C.GunaratneJ.CohenS. M.ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation2013274441449CzajaM. J.DingW. X.DonohueT. M.Jr.Functions of autophagy in normal and diseased liver20139811311158TikhanovichI.KuraviS.CampbellR. V.KharbandaK. K.ArtiguesA.VillarM. T.WeinmanS. A.Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure20145915870KopycinskaJ.Kempińska-PodhorodeckaA.HaasT.EliasE.DePinhoR. A.PaikJ.MilkiewiczP.MilkiewiczM.Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis2013332231238WuT.ZhaoF.GaoB.TanC.YagishitaN.NakajimaT.WongP. K.ChapmanE.FangD.ZhangD. D.Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis201410.1101/gad.238246.114YanZ.TanW.DanY.ZhaoW.DengC.WangY.DengG.Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population201213, article 49MiceliV.CocciadiferroL.FregapaneM.ZarconeM.MontaltoG.PolitoL. M.AgostaraB.GranataO. M.CarrubaG.Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression20111553133172-s2.0-7995608861510.1089/omi.2010.0108QuaynorS. D.Stradtman JrE. W.KimH. G.ShenY.ChorichL. P.SchreihoferD. A.LaymanL. C.Delayed puberty and estrogen resistance in a woman with estrogen receptor α variant20133692164171CleggD. J.PalmerB. F.Effects of an estrogen receptor α variant20133691716631664MoeiniA.CornellàH.VillanuevaA.Emerging signaling pathways in hepatocellular carcinoma2012128393VranicS.GatalicaZ.DengH.Frkovic-GrazioS.LeeL. M. J.GurjevaO.WangZ.-Y.ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast201164154572-s2.0-7865081279710.1136/jcp.2010.082776ChaudhriR. A.Olivares-NavarreteR.CuencaN.HadadiA.BoyanB. D.SchwartzZ.Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36)201228710716971812-s2.0-8485775683110.1074/jbc.M111.292946WangJ.LiJ.FangR.XieS.WangL.XuC.Expression of ERα36 in gastric cancer samples and their matched normal tissues2012311721752-s2.0-8485521143710.3892/ol.2011.437ZhangX. T.DingL.KangL. G.WangZ. Y.Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells201227620572065ChaudhriR. A.Olivares-NavarreteR.CuencaN.HadadiA.BoyanB. D.SchwartzZ.Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36)201228710716971812-s2.0-8485775683110.1074/jbc.M111.292946Di MaioM.DanieleB.PignataS.GalloC.De MaioE.MorabitoA.PiccirilloM. C.PerroneF.IS human hepatocellular carcinoma a hormone-responsive tumor?20081411168216892-s2.0-4184911414410.3748/wjg.14.1682CenterM. M.JemalA.International trends in liver cancer incidence rates20112011236223682-s2.0-8115512612210.1158/1055-9965.EPI-11-0643VenookA. P.PapandreouC.FuruseJ.de GuevaraL. L.The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective201015supplement 45132-s2.0-79952277505